References
- BOWLING, A. (1997). Research methods in health: investigating health and health services. Buckingham: Open University Press.
- BRITISH LIVER TRUST (2003). http://www.britishlivertrust.org.uk/content/diseases/hepatitis_c.asp, (May). BRITISH MEDICAL ASSOCIATION (1997). The Misuse of Drugs. The Netherlands: Harwood.
- BUDD, J., COPELAND, L., ELTON, R.A. & ROBERTSON, J.R. (2002). Hepatitis C infections in a cohort of injecting drug users—past and present risk factors and the implications for educational and clinical management. The European Journal of General Practice, 8, 95–100.
- CHRISTO, G. (1998). A review of reasons for using or not using drugs: commonalities between sociological and clinical perspectives. Drugs: education, prevention and policy, 5(1),59–72.
- COYLE, D., GODFREY, C., HARDMAN, G. & RAISTRICK, D. (1997). Costing substance misuse services. Addiction, 92(8),1007–1015.
- CROFTS, N., AITKEN, C.K. & KALDOR, J.M. (1999). The force of numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is not. Medical Journal of Australia, 170, 220–221.
- FOSTER, J.H., MARSHALL, E.J. & PETERS, T.J. (2001). Community alcohol services: a call for a proactive response. The Drug and Alcohol Professional, 1(1),8–12.
- GARFEIN, R.S., DOHERTY, M.C., MONTERROSO, E.R., THOMAS, D.L., NELSON, K.E. & VLAHOV, D. (1998). Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18(1),S12–S19.
- GIDDENS, A. (1991). Modernity and self-identity: self and society in the late modern age. Cambridge: Polity Press.
- GOLDBERG, D., CAMERON, S. & MCMENAMIN, J. (1998). Hepatitis C virus antibody prevalence among injecting drug users in Glasgow has fallen but remains high. Communicable Disease and Public Health, 1(2),95–97.
- GORMAN, D.M. & BROWN, G.W. (1992). Recent developments in life-event research and their relevance for the study of addictions. British Journal of Addiction, 87, 837–849.
- GRASSI, L., SATRIANO, J., SERRA, A., BIANCOSINO, B., ZOTOS, S., SIGHINOLFI, L. & GHINELLI, F. (2002). Emotional stress, psychosocial variables and coping associated with hepatitis C virus and human immuno- deficiency virus infections in intravenous drug users. Psychotherapy and Psychosomatics, 71, 342–349.
- HAGAN, H., THEIDE, H., WEISS, N.S., HOPKINS, S.G., DUCHIN, J.S. & ALEXANDER, E.R. (2001). Sharing of drug preparation equipment as a risk factor for hepatitis C. American Journal of Public Health, 91, 42–46.
- HUTCHINSON, S.J., MCINTYRE, P.G., MOLYNEAUX, P., CAMERON, S., BURNS, S., TAYLOR, A. & GOLDBERG, D.J. (2002).Prevalence of hepatitis C among injectors in Scotland 1989–2000: declining trends among young injectors halt in the late 1990s. Epidemiology and Infection, 128(3),473–477.
- JUDD, A., HICKMAN, M., RENTON, A. & STIMSON, G. (1999). Hepatitis C virus infection among injecting drug users: has harm reduction worked? Addiction Research, 7(1),1–6.
- MCINTOSH, J. & MCKEGANEY, N. (2000). Addicts’ narratives of recovery from drug use: constructing a non-addict identity. Social Science and Medicine, 50, 1501–1510.
- MULLEN, P.E., MARTIN, J.L., ANDERSON, J.C., ROMANS, S.E. & HERBISON, G.P. (1996). The long-term impact of the physical., emotional and sexual abuse of children: a community study. Child Abuse and Neglect, 20(1),7–21.
- NEALE, J. (1998). Drug users’ views of drug service providers. Health and Social Care in the Community, 6(5),308–317.
- POWER, R., JONES, S., KEARNS, G., WARD, J., GIBSON, N., PERERA, J. & SMITH, J. (1995). Coping with illicit drug use. London: HMSO.
- RODGER, A.J., JOLLEY, D., THOMPSON, S.C., LANIGAN, A. & CROFTS, N. (1999). The impact of diagnosis on hepatitis C virus on quality of life. Hepatology, 30(5),1299–1301.
- ROSS, M.W., WODAK, A., STOWE, A. & GOLD, J. (1994). Explanations for sharing injection equipment in injecting drug users and barriers to safer drug use. Addiction, 89(4),473–9.
- SCAIFE, B., GILL, P., HEYWOOD, P. & NEAL, R. (2000). Socioeconomic characteristics of adult frequent attenders in general practice: secondary analysis of data. Family Practice, 17(4),298–304
- SCOTTISH CENTRE FOR INFECTION AND ENVIRONMENTAL HEALTH (2003). http://www.show.scot.nhs.uk/SCIEH/, (May).
- SINGH, S., MILLER, R., MADGE, S. & PATCH, D. (2000). The impact of hepatitis C in General Practice. British Journal of General Practice, 50(456), 532, & 535–536.
- SLADDEN, T.J., HICKEY, A.R., DUNN, T.M. & BEARD, J.R. (1998). Hepatitis C virus infection: impacts on behaviour and lifestyle. Australian and New Zealand Journal of Public Health, 22(4),509–511.
- SMYTH, B.P., MCMAHON, J., O’CONNOR, J.J. & RYAN, J. (1999). Knowledge regarding hepatitis C among injecting drug users. Drugs: education, prevention and policy, 6(2),257–264.
- STEIN, M.D., MAKSAD, J. & CLARKE, J. (2001). Hepatitis C disease among injection drug users: knowledge, perceived risk and willingness to receive treatment. Drug and Alcohol Dependence, 61, 211–215.
- STRANG, J., GOSSOP, M. & STIMSON, G. (1988). Courses of drug use: the concepts of career and natural history. In A.H. Ghodse & J.D. Maxwell (eds). Drug abuse and dependence: an introduction for the caring professions. London: Macmillan.
- STRATHDEE, S.A., PATRICK, D.M., CURRIE, S.L., CORNELISSE, P.G., REKART, M.L., MONTANER, J.S., SCHECHTER,
- M.T. & O’SHAUGHNESSY, M.V. (1997). Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS, 11(8),F59–65.
- SUTHERLAND, I. & SHEPHERD, J.P. (2001). Social dimensions of adolescent substance use. Addiction, 96, 445–458.
- VAN AMEIJDEN, E.J., VAN DEN HOEK, J.A., MIEJENTJES, G.H. & COUTINHO, R.A. (1993). A longitudinal study on the incidence and transmission patterns of HIV, HBV, and HCV infection among drug users in Amsterdam. European Journal of Epidemiology, 9(3),255–262.
- VAN BEEK, I., DWYER, R., DORE, G.J., LUO, K. & KALDOR, J.M. (1998). Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study. British Medical Journal, 317, 433–437.